Panadol shortage

Published September 24, 2022

FROM headaches to fever to bodily pain — paracetamol is used ubiquitously in Pakistan as the go-to remedy for most common ailments. In recent months, the drug’s most familiar brand, ‘Panadol’, has been in short supply in the country. The company that manufactures Panadol had recently halted production, saying that it is no longer viable to keep producing the drug due to higher input prices. Though the drug itself, paracetamol, is still available and is being sold under other names, such is the power of the brand that the disappearance of Panadol from pharmacy shelves has been taken by many to mean that there is a shortage of medicine to treat fever and common pains. Other companies manufacturing paracetamol had also raised issues relating to pricing.

The authorities know they have a problem on their hands, but they seem to be struggling with how to fix it. Drug pricing, which is controlled through the Drug Regulatory Authority of Pakistan, has become a political issue over the years as various parties have lobbied to block any price increases in a bid to win favour with the public. What makes matters more complicated is that Pakistan does not produce many active ingredients required to manufacture drugs, even some of the most commonly used ones, which means the industry remains highly dependent on the import of raw materials to continue production. These imports have in recent months been vulnerable to global supply shortages and disruptions, as well as currency rate depreciation. The combined effect of these factors has put drug manufacturers under pressure, as they are having difficulty meeting costs while the government does not allow them to raise prices. The prime minister has now announced that the government will subsidise paracetamol production to keep it ‘affordable’ for the masses. This is unlikely to work as a long-term fix for a cash-starved economy. At some point, the government will have to realise that the availability of drugs is sometimes more important than affordability. With dengue ripping through the country and the cold and flu season right around the corner, demand for paracetamol is expected to remain strong or even pick up in the weeks to come. The government may, by all means, take action to prevent hoarding of medicines and illicit profiteering by black marketeers. However, it needs to get the economics of the drugs market right if it wants to prevent similar crises in the future.

Published in Dawn, September 24th, 2022

Opinion

Editorial

Ill omens
Updated 12 Feb, 2025

Ill omens

One wonders whether institutional leadership realises the long-term ramifications of the ongoing "remaking" of judiciary.
Sunken dreams
12 Feb, 2025

Sunken dreams

ANOTHER tragedy has struck Pakistani migrants seeking a better future. A boat capsizing off the Libyan coast has ...
Hate in India
12 Feb, 2025

Hate in India

HISTORY shows that rulers use hate speech to provoke hate crimes and ‘othering’ among communities. Indian Prime...
IMF scrutiny
Updated 11 Feb, 2025

IMF scrutiny

Strengthening foundations of the economic superstructure will help make the economy competitive and boost growth.
Shadow voices
11 Feb, 2025

Shadow voices

OVER the weekend, another ‘open letter’ addressed to the army chief and attributed to former prime minister ...
Paradise at a premium
11 Feb, 2025

Paradise at a premium

PAKISTAN’S recent triumph at the New York Travel and Adventure Show 2025, winning the Best Partner Pavilion Award,...